No Picture
Trading Ideas

UPDATE 1-Correvio slips after FDA staffers say benefits of heart drug do not outweigh risks

U.S. Food and Drug Administration staffers reviewing Correvio Pharma Corp’s heart drug said on Friday they did not believe the benefits offered by the therapy outweighed its risks, sending the company’s shares down 14%. The drug, Brinavess, approved in several other counties including Europe and Canada, aims to correct erratic heart rhythm in the upper chambers of the heart due to a condition known as atrial fibrillation or AFib. Although Correvio has provided sufficient evidence of the drug’s benefit, Brinavess comes with “serious liabilities” including low blood pressure, irregular heartbeats in the lower heart chambers, and death, the …read more […]

No Picture
Business News

Aston Martin CEO says shareholders in it for the long-term, not soliciting participation

Aston Martin’s two major shareholders are in it for the long term and the company is not actively soliciting participation, the firm’s boss said on Friday after a media report said Lawrence Stroll, owner of Formula One team Racing Point, is preparing a bid for a major stake.

…read more […]

No Picture
Trading Ideas

Retail Stocks

Contrary to what you may have heard, physical retail isn’t dead. True, some retailers have struggled mightily in the wake of rapid industry disruption by Amazon (Nasdaq: AMZN) and the rise of e-commerce. But there are plenty of investment opportunities available to you when it comes to retail stocks.
Perhaps no activity belongs to the fabric of what it is to be America more than shopping does. Whether done in traditional brick-and-mortar stores or through online portals, Americans will continue to shop in any foreseeable future. So expect retail stocks to continue producing profits for you for many years to come.

What …read more […]

No Picture
Trading Ideas

Belgium's UCB says psoriasis drug beats AbbVie's Humira in trial

UCB SA said on Friday its experimental plaque psoriasis drug produced better results compared to AbbVie Inc’s blockbuster drug, Humira, in reducing the severity of the disease. UCB’s drug, bimekizumab, also met the main goal of clearing or almost clearing the skin of plaques or rashes in a late-stage study, as assessed by an investigator, according to the Belgium-based company. AbbVie’s Humira is the world’s top selling drug and treats rheumatoid arthritis and psoriasis. …read more […]

No Picture
Trading Ideas

U.S. Democratic contender Sanders proposes $150 billion for 'high-speed internet for all'

U.S. Democratic presidential contender Bernie Sanders launched a plan on Friday to provide high-speed broadband for every U.S. household at a cost of $150 billion, pledging to use antitrust powers to take on internet, telecom and cable companies. Sanders, a leading candidate in the crowded field seeking the Democratic nomination to take on Republican President Donald Trump in the November 2020 election, said the funding would go toward infrastructure grants and technical assistance to local governments to build out publicly owned networks. …read more […]